Skip to main content

Peer Review reports

From: Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate); the first generation specific tyrosine kinase inhibitor

Original Submission
30 Sep 2009 Submitted Original manuscript
19 Nov 2009 Reviewed Reviewer Report - Elena Tothova
16 Mar 2010 Reviewed Reviewer Report - Michael Mauro
29 Mar 2010 Author responded Author comments - Aaron Mansfield
Resubmission - Version 2
29 Mar 2010 Submitted Manuscript version 2
30 Mar 2010 Author responded Author comments - Aaron Mansfield
Resubmission - Version 3
30 Mar 2010 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
25 Nov 2010 Author responded Author comments - Aaron Mansfield
Resubmission - Version 5
25 Nov 2010 Submitted Manuscript version 5
Publishing
7 Dec 2010 Editorially accepted
7 Dec 2010 Article published 10.1186/1471-2326-10-8

You can find further information about peer review here.

Back to article page